Long-term effects of acoramidis on mortality in variant transthyretin amyloid cardiomyopathy, including p.Val142Ile: findings from the open-label extension of ATTRibute-CM

Frederick L Ruberg, Margot K Davis, Sarah A M Cuddy, Lily K Stern, Olakunle Akinboboye, Keyur Shah, Nitasha Sarswat, Michel G Khouri, Daniel P Judge, Jan M Griffin, Justin L Grodin, Souhiela Fawaz, Bret Zeldow, Jean-François Tamby, Adam Castaño, Uma Sinha, Marianna Fontana, Julian Gillmore, Kevin M Alexander

Open source

DOI: 10.1093/ejhf/xuag258
Published: 2026-08-30
Container: European Journal of Heart Failure
Publisher: Oxford University Press (OUP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/ejhf/xuag258,
  title = {Long-term effects of acoramidis on mortality in variant transthyretin amyloid cardiomyopathy, including p.Val142Ile: findings from the open-label extension of ATTRibute-CM},
  author = {Frederick L Ruberg and Margot K Davis and Sarah A M Cuddy and Lily K Stern and Olakunle Akinboboye and Keyur Shah and Nitasha Sarswat and Michel G Khouri and Daniel P Judge and Jan M Griffin and Justin L Grodin and Souhiela Fawaz and Bret Zeldow and Jean-François Tamby and Adam Castaño and Uma Sinha and Marianna Fontana and Julian Gillmore and Kevin M Alexander},
  year = {2026},
  journal = {European Journal of Heart Failure},
  doi = {10.1093/ejhf/xuag258},
  url = {https://doi.org/10.1093/ejhf/xuag258}
}

RIS

TY  - JOUR
TI  - Long-term effects of acoramidis on mortality in variant transthyretin amyloid cardiomyopathy, including p.Val142Ile: findings from the open-label extension of ATTRibute-CM
AU  - Frederick L Ruberg
AU  - Margot K Davis
AU  - Sarah A M Cuddy
AU  - Lily K Stern
AU  - Olakunle Akinboboye
AU  - Keyur Shah
AU  - Nitasha Sarswat
AU  - Michel G Khouri
AU  - Daniel P Judge
AU  - Jan M Griffin
AU  - Justin L Grodin
AU  - Souhiela Fawaz
AU  - Bret Zeldow
AU  - Jean-François Tamby
AU  - Adam Castaño
AU  - Uma Sinha
AU  - Marianna Fontana
AU  - Julian Gillmore
AU  - Kevin M Alexander
PY  - 2026
JO  - European Journal of Heart Failure
DO  - 10.1093/ejhf/xuag258
UR  - https://doi.org/10.1093/ejhf/xuag258
ER  -

APA

Ruberg, F. L., Davis, M. K., Cuddy, S. A. M., Stern, L. K., Akinboboye, O., Shah, K., Sarswat, N., Khouri, M. G., Judge, D. P., Griffin, J. M., Grodin, J. L., Fawaz, S., Zeldow, B., Tamby, J., Castaño, A., Sinha, U., Fontana, M., Gillmore, J., & Alexander, K. M. (2026). Long-term effects of acoramidis on mortality in variant transthyretin amyloid cardiomyopathy, including p.Val142Ile: findings from the open-label extension of ATTRibute-CM. European Journal of Heart Failure. https://doi.org/10.1093/ejhf/xuag258

Source records

crossref · retrieved 2026-09-26T13:52:08.483Z